首页> 外文期刊>Analytical methods >Development and validation of a non-aqueous capillary electrophoresis method for the determination of imatinib, codeine and morphine in human urine
【24h】

Development and validation of a non-aqueous capillary electrophoresis method for the determination of imatinib, codeine and morphine in human urine

机译:非含水毛细管电泳法测定伊马替尼,可待因和吗啡中的非含水毛细管电泳方法的开发及验证

获取原文
           

摘要

A non-aqueous capillary electrophoresis (NACE) method that separates a tyrosine kinase inhibitor, imatinib, together with its main metabolite and two analgesics, codeine and morphine, from human urine is proposed. After a solid phase extraction step in urine, the four drugs were separated through a fused-silica capillary at 22 kV and 25 ?°C and detected at 207 nm. For this purpose 15 mM ammonium acetate and 1% acetic acid in methanol were used as the background electrolyte. Detection limits of 130 and 80 ??g La?’1 for imatinib and its metabolite and 40 and 60 ??g La?’1 for codeine and morphine were obtained. According to the validation study, the developed method was proved to be accurate, precise, sensitive and specific. The developed method is simple, rapid and sensitive and has been used to determine imatinib, codeine and their metabolites at clinically relevant levels in human urine from different patients under leukemia or analgesic treatment.
机译:提出了一种非含水毛细管电泳(NACE)方法,其将酪氨酸激酶抑制剂,伊马替尼与其主要代谢物和两种镇痛药,可口碱和吗啡一起分离在一起。 在尿液中的固相萃取步骤之后,将四种药物通过22kV和25℃的熔融二氧化硅毛细管分离,并在207nm处检测。 为此目的,使用15mM乙酸铵和1%甲醇中的乙酸作为背景电解质。 为伊马替尼及其代谢物和40〜60〜60?1的检测限为130和80?1。 根据验证研究,证明了开发的方法是准确,精确,敏感和特异性的。 开发方法简单,快速和敏感,已被用于从白血病或镇痛治疗下的不同患者的人类尿液中的临床相关水平确定伊马替尼,可待因及其代谢物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号